logo
welcome
The Motley Fool

The Motley Fool

Why Viking Therapeutics Stock Plummeted by 24% in December

The Motley Fool
Summary
Nutrition label

69% Informative

Viking Therapeutics' share price eroded by 24% in December , primarily on the back of a rival's aggressive move into a potentially lucrative segment of the pharmaceutical market.

Merck announced it had entered into a licensing deal with China -based biotech Hansoh Pharma for that company's investigational weight-loss drug.

If developed successfully, the drug would surely pose a serious threat to Viking's No. 1 pipeline program.

VR Score

58

Informative language

50

Neutral language

17

Article tone

semi-formal

Language

English

Language complexity

45

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

7

https://www.fool.com/investing/2025/01/04/why-viking-therapeutics-stock-plummeted-by-24-in-d/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=ac4b7465-0725-4941-a50a-4ed399ea9978https://www.fool.com/investing/2024/12/20/why-viking-therapeutics-tumbled-by-more-than-10-th/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=ac4b7465-0725-4941-a50a-4ed399ea9978https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=b8f51fe9-4a45-4427-a592-55cf5f01340c&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fa-sa-dd-3%3Faid%3D9431%26source%3Disaeditxt0010984%26ftm_cam%3Dsa-dd%26ftm_pit%3D16623%26ftm_veh%3Darticle_pitch_feed_yahoo&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=ac4b7465-0725-4941-a50a-4ed399ea9978https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=b8f51fe9-4a45-4427-a592-55cf5f01340c&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fa-sa-dd-3%3Faid%3D9431%26source%3Disaeditxt0010984%26ftm_cam%3Dsa-dd%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D16623&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=ac4b7465-0725-4941-a50a-4ed399ea9978https://www.fool.com/investing/stock-market/market-sectors/healthcare/biotech-stocks/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=ac4b7465-0725-4941-a50a-4ed399ea9978https://www.fool.com/legal/fool-disclosure-policy/https://www.fool.com/author/4067/

Source diversity

2

Affiliate links

no affiliate links